Oxford Biomedica plc (LON:OXB – Get Free Report) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of GBX 420.59 ($5.29) and traded as high as GBX 426 ($5.36). Oxford Biomedica shares last traded at GBX 421.50 ($5.30), with a volume of 43,576 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft increased their price objective on Oxford Biomedica from GBX 250 ($3.15) to GBX 380 ($4.78) and gave the company a “hold” rating in a report on Tuesday, September 24th.
Check Out Our Latest Research Report on OXB
Oxford Biomedica Stock Performance
About Oxford Biomedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
- Five stocks we like better than Oxford Biomedica
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Where Do I Find 52-Week Highs and Lows?
- These 3 Quirky ETFs May Be Strong Plays in 2025
- What Are Dividend Challengers?
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.